HomeOpen Access NewsSH Manus Neurodynamica Limited

SH Manus Neurodynamica Limited

Novel digital biomarkers to aid in the diagnosis and tracking of symptoms in patients with Parkinson’s Disease

Dr Rutger Zietsma – CEO at Manus Neurodynamica Ltd – and PD Dr Angela Deutschländer share their vision on earlier diagnosis and objective symptom tracking with the NeuroMotor PenTM.

No posts to display

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders